Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 40 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Panidis, Dimitrios [Clear All Filters]
Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome..
Eur J Obstet Gynecol Reprod Biol. 156(2), 181-5.
(2011). Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome..
Endocr J. 59(1), 21-9.
(2012). Plasma von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome..
Hormones (Athens). 11(1), 77-85.
(2012). Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome..
Gynecol Endocrinol. 29(3), 250-3.
(2013). Prevalence of metabolic syndrome in women with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 78(4), 586-92.
(2013). The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 80(3), 432-8.
(2014). Semen analysis by electron and fluorescence microscopy in a case of partial hydatidiform mole reveals a high incidence of abnormal morphology, diploidy, and tetraploidy..
Fertil Steril. 95(7), 2430.e1-5.
(2011). Serum AMH, FSH, and LH levels in PCOS..
Fertil Steril. 93(3), e13; author reply e14.
(2010). Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels..
Med Hypotheses. 77(4), 649-53.
(2011). Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome..
J Bone Miner Metab. 29(2), 201-6.
(2011). Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study..
Angiology. 61(6), 595-601.
(2010). Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome..
Eur J Obstet Gynecol Reprod Biol. 163(2), 185-9.
(2012). Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?.
Gynecol Endocrinol. 26(9), 698-703.
(2010). Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome..
Endocr Pract. 20(6), 540-7.
(2014). Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome..
Gynecol Endocrinol. 28(1), 20-4.
(2012).